59 web-programmer-developer-"INSERM" Postdoctoral positions at Yale University in United States
Sort by
Refine Your Search
-
acquired DNA alterations in normal cells and in cancer development. The successful applicant will work independently, perform experiments, develop and optimise assays, and analyse, interpret, and present
-
-developing and conducting research projects and studies, writing peer-reviewed articles, and formulating new research questions for future analysis. We are looking for individuals with a background in data
-
/157824. The deadline for receipt of all application materials is January 15, 2025, and successful candidates are expected to begin their program at Yale between July 1 and December 31, 2025. Questions
-
biomedical engineering, physics, or a related field is required. The successful candidate will be expected to plan PET imaging studies, conduct them together with a team of other scientists and research
-
to improving outcomes for students and aligns with its work to develop public education leaders. Unlike many postdoctoral opportunities in education, this associateship is a unique opportunity for education
-
position will provide an excellent opportunity for an early career economist or political scientist to develop top-tier research with mentorship by Professor Rohini Pande and additional Principal
-
are one of the most exciting areas of cancer biology. Many novel strategies for targeting RAS are in clinical trial, and many more are in development and are advancing to clinical trials. The Stites lab’s
-
. Opportunities for presentations at local, regional, and national meetings, manuscript writing, grant preparation, and professional development. Qualifications: MD, PhD, PharmD, or equivalent degree. Background in
-
: - Develop and implement AI models to study and optimize TCR and BCR interactions, enhancing receptor design for improved binding affinity, specificity, and therapeutic effectiveness. - Collaborate with
-
science will be rooted in basic biology and have a strong translational perspective towards developing novel therapeutics for cancer patients. Principal Investigator Background/Research: Dr. Zaidi (MD/PhD